Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Cardiovascular risk factors in long‐term followup after orthotopic liver transplantation
1997
Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic/Reperfusion Injury
1999
Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
1999
Renal transplantation following previous heart, liver, and lung transplantation: An 8-year single-center experience
2001
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Hepatocellular carcinoma
2003 Standout
Delayed graft function in kidney transplantation
2004 Standout
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors
2003
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Predictive factors for early mortality following liver transplantation
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
FK506 and the role of immunophilins in nerve regeneration
1997
Switching from Cyclosporine to Tacrolimus in Patients with Chronic Transplant Dysfunction or Cyclosporine-Induced Adverse Events
2004
Effective oral administration of tacrolimus in renal transplant recipients
2001
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Predictors of renal function following lung or heart-lung transplantation
2002
Hypoxia and Inflammation
2011 Standout
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
1999
The cellular and molecular basis of hyperthermia
2002 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
1999 Standout
Hepatocellular carcinoma
2012 Standout
New Immunosuppressive Agents for Maintenance Therapy in Organ Transplantation
1997
Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future
2000
Global epidemiology and outcomes of acute kidney injury
2018 Standout
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
2010 StandoutNobel
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Gout
2009 Standout
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice
2004
THE SAFETY AND EFFICACY OF A TWO-DOSE DACLIZUMAB (ZENAPAX) INDUCTION THERAPY IN LIVER TRANSPLANT RECIPIENTS1
2000
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
1997
Management of Hepatocellular Carcinoma *
2005 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Pathologic Classification of Diabetic Nephropathy
2010 Standout
CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION
1998
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
2000
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment
2003
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity
2002
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
2001
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
2005 Standout
Indications for Mycophenolate Mofetil Therapy in Hepatitis C-Patients Undergoing Liver Transplantation
1998
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Tacrolimus
1997
Pathophysiology and pharmacologic treatment of acute spinal cord injury*1
2004 Standout
Mycophenolate mofetil and its mechanisms of action
2000 Standout
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
Impact of human leukocyte antigen matching in liver transplantation
2003
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
The Use of Tacrolimus in Pediatric Liver Transplantation
1998
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation
2010
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up
2004
Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
1997
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION
2001
Neurological complications after orthotopic liver transplantation
2007
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance
2001
Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients
2002
The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation
2005 StandoutNobel
Hospital-acquired renal insufficiency
2002 Standout
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation
2002
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study
2001
Interleukin-8 Release during Early Reperfusion Predicts Graft Function in Human Lung Transplantation
2002
Ischemia–Reperfusion–induced Lung Injury
2003
A selective role of calcineurin Aα in synaptic depotentiation in hippocampus
1999 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Role of platelets in chronic liver disease and acute liver injury
2013
Therapeutic Monitoring of Tacrolimus
1998
Ischemic Cell Death in Brain Neurons
1999 Standout
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol
2001 Standout
Works of Klaus‐Peter Platz being referenced
The optimal immunosuppressant after liver transplantation according to diagnosis: Cyclosporine A or FK506?
1995
Technique and Results of Biliary Reconstruction Using Side-to-Side Choledochocholedochostomy in 300 Orthotopic Liver Transplants
1994
CYTOKINE PATTERN DURING REJECTION AND INFECTION AFTER LIVER TRANSPLANTATION-IMPROVEMENTS IN POSTOPERATIVE MONITORING?
1996
THE RELEASE OF CYTOKINES, ADHESION MOLECULES, AND EXTRACELLULAR MATRIX PARAMETERS DURING AND AFTER REPERFUSION IN HUMAN LIVER TRANSPLANTATION
1996
Early postoperative complications following liver transplantation
2004
COMPARISON OF FK506- AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER TRANSPLANTATION
1995
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients
1994
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1994
Management of Acute Steroid‐Resistant Rejection after Liver Transplantation
1996
NEUROTOXICITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION
1994
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
1994